Moderna +10% after-hours as Moderna agrees to pay up to $2.25B to settle COVID vaccine patent dispute

Source: [https://finance.yahoo.com/news/moderna-agrees-pay-2-25-212613359.html](https://finance.yahoo.com/news/moderna-agrees-pay-2-25-212613359.html)

>Moderna has agreed to pay Genevant Sciences, a ‌subsidiary of Roivant Sciences, and Arbutus ‌Biopharma up to $2.25 billion to settle a ​long-running legal fight over the technology that made its COVID-19 vaccine possible, the companies said on Tuesday.

>Under the deal, ‌Moderna will ⁠pay $950 million upfront in July 2026, with an additional $1.3 billion ⁠that depends on the outcome of a separate legal appeal.

>In extended trading, ​Moderna's shares ​jumped more than ​10%, Arbutus rose ‌11%, while Roivant was up about 1%.

>The deal resolves all U.S. and international legal actions accusing Moderna of using lipid nanoparticle, or LNP, a delivery ‌technology owned by ​Genevant and Arbutus, without ​permission in ​its COVID‑19 shot, Spikevax.

>LNP technology ‌acts as a tiny ​protective shell ​that helps fragile mRNA molecules reach human cells intact, a key ​component that ‌allows mRNA vaccines to work.

https://preview.redd.it/svbkm91jgwmg1.png?width=1682&format=png&auto=webp&s=5abdb72fb2b1ce51412141e3f6eb063b6e0f0263